Related Experiment Video

Updated: Sep 6, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

NATIONAL ASSESSMENT OF PNEUMONIA MORBIDITY IN CHILDREN IN THE PERIOD 1993-2017 AND PROGNOSIS FOR 2025

Eugenia I Vezhnovets1, Yuriy B Yashchenko1, Vitalyi G Gurianov2

  • 1STATE INSTITUTION OF SCIENCE «RESEARCH AND PRACTICAL CENTER OF PREVENTIVE AND CLINICAL MEDICINE» STATE ADMINISTRATIVE DEPARTMENT, KYIV, UKRAINE.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|June 27, 2022
PubMed

Insights

Pneumonia incidence in Ukrainian children aged 0-17 years remains high, exceeding European rates. Projections indicate a concerning rise in adolescent pneumonia by 2025, necessitating a national health strategy.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Pneumonia poses a significant public health challenge in Ukraine.
  • Understanding national trends in pediatric pneumonia morbidity is crucial for effective intervention.

Purpose of the Study:

  • To analyze national pneumonia morbidity trends in Ukrainian children (0-17 years) from 1993-2017.
  • To predict future pneumonia incidence dynamics up to 2025.

Main Methods:

  • Utilized data from the Center for Medical Statistics of the Ministry of Health of Ukraine (1993-2017).
  • Calculated pneumonia morbidity rates across distinct pediatric age groups (0-6, 7-14, 15-17 years).

Main Results:

  • High pneumonia incidence observed in Ukrainian children (6.74–8.21 per 1000) between 1993-2017.
  • Specific rates: 0-6 years (11.45–11.17), 7-14 years (4.65–6.46), 15-17 years (1.99–10.47).
  • Ukrainian rates significantly surpassed those in European countries; projected 2025 rate for under-6s is 3.84 per 1000.

Conclusions:

  • A significant increase in adolescent pneumonia morbidity is predicted by 2025.
  • A national strategy for child and adolescent health improvement is essential.
  • Policy and management measures are needed for effective pneumonia prevention and treatment.
Abstract

Keywords:
childrenmorbidity ratenational trendspneumonia

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.4K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
425
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
325
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
440
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
511
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K